Advanced search
Publication Cover
OncoTargets and Therapy Volume 17, 2024 - Issue
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report

Danfei ZhouDepartment of Respiratory and Critical Care Medicine, Ningbo No.2 Hospital, Ningbo, People’s Republic of ChinaView further author information
,
Jun YingDepartment of Respiratory and Critical Care Medicine, Ningbo No.2 Hospital, Ningbo, People’s Republic of ChinaView further author information
,
Shanshan HuDepartment of Respiratory and Critical Care Medicine, Ningbo No.2 Hospital, Ningbo, People’s Republic of ChinaView further author information
,
Jiangdong LiDepartment of Respiratory and Critical Care Medicine, Ningbo No.2 Hospital, Ningbo, People’s Republic of ChinaView further author information
&
Haijian LiuDepartment of Respiratory and Critical Care Medicine, Ningbo No.2 Hospital, Ningbo, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 261-265 | Received 13 Oct 2023, Accepted 19 Mar 2024, Published online: 26 Mar 2024

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Devarakonda S, Morgensztern D, Govindan R. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015;16(7):e342–351. doi:10.1016/S1470-2045(15)00077-7
  • Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–566. doi:10.1038/nature05945
  • Yoshida T, Oya Y, Tanaka K, et al. Differential crizotinib response duration among ALK fusion variants in ALK-positive non-small-cell lung cancer. J Clin Oncol. 2016;34(28):3383–3389. doi:10.1200/JCO.2015.65.8732
  • Ou SI, Zhu VW, Nagasaka M. Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020. JTO Clin Res Rep. 2020;1(1):100015. doi:10.1016/j.jtocrr.2020.100015
  • Barlesi F, Mazieres J, Merlio JP, et al. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. 2016;387(10026):1415–1426. doi:10.1016/S0140-6736(16)00004-0
  • Zhang J, Zou C, Zhou C, et al. A Novel Linc00308/D21S2088E intergenic region ALK fusion and its enduring clinical responses to crizotinib. J Thorac Oncol. 2020;15(6):1073–1077. doi:10.1016/j.jtho.2020.03.009
  • Pekar-Zlotin M, Hirsch FR, Soussan-Gutman L, et al. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer. Oncologist. 2015;20(3):316–322. doi:10.1634/theoncologist.2014-0389
  • Li W, Liu Y, Li W, Chen L, Ying J. Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in NSCLC. J Thorac Oncol. 2020;15(7):1223–1231. doi:10.1016/j.jtho.2020.02.023
  • Wang C, Chen S, He Q, Sun T, Xu P. A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: a case report. Invest New Drugs. 2022;40(6):1350–1353. doi:10.1007/s10637-022-01262-2
  • Wang T, Du G, Niu M, Liu R. A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma. BMC Pulm Med. 2023;23(1):60. doi:10.1186/s12890-023-02351-5
  • Shaw AT, Varghese AM, Solomon BJ, et al. Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer. Ann Oncol. 2013;24(1):59–66. doi:10.1093/annonc/mds242
  • Noonan SA, Camidge DR. PROFILE 1014: lessons for the new era of lung cancer clinical research. Transl Lung Cancer Res. 2015;4(5):642–648. doi:10.3978/j.issn.2218-6751.2015.05.02

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.